Rimeporide
CAS No. 187870-78-6
Rimeporide ( EMD87580 | EMD-87580 )
产品货号. M12914 CAS No. 187870-78-6
Rimeporide (EMD87580) 是一种有效的选择性钠氢交换器 NHE1 抑制剂。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥478 | 有现货 |
|
| 5MG | ¥786 | 有现货 |
|
| 10MG | ¥1442 | 有现货 |
|
| 25MG | ¥3216 | 有现货 |
|
| 50MG | ¥4714 | 有现货 |
|
| 100MG | ¥6715 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Rimeporide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Rimeporide (EMD87580) 是一种有效的选择性钠氢交换器 NHE1 抑制剂。
-
产品描述Rimeporide (EMD87580) is a potent, selective sodium hydrogen exchanger NHE1 inhibitor, show promise as potential therapeutic agents for the treatment of heart failure.Heart Failure Discontinued(In Vitro):Blocking NHE-1 activity has been shown to decrease intracellular Na+ and Ca2+ overload and pH and Rimeporide (EMD-87580) represents a new therapeutic option for duchenne muscular dystrophy (DMD). Rimeporide (EMD-87580) is expected to act as a muscle-sparing agent and its mode of action means that it is mutation independent.
-
体外实验Blocking NHE-1 activity has been shown to decrease intracellular Na+ and Ca2+ overload and pH and Rimeporide (EMD-87580) represents a new therapeutic option for duchenne muscular dystrophy (DMD). Rimeporide (EMD-87580) is expected to act as a muscle-sparing agent and its mode of action means that it is mutation independent.
-
体内实验——
-
同义词EMD87580 | EMD-87580
-
通路Membrane Transporter/Ion Channel
-
靶点Sodium Channel
-
受体NHE-1
-
研究领域——
-
适应症——
化学信息
-
CAS Number187870-78-6
-
分子量333.377
-
分子式C11H15N3O5S2
-
纯度>98% (HPLC)
-
溶解度DMSO: 15 mg/mL,50 mM ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCC1=CC(=C(C=C1C(=O)NC(=N)N)S(=O)(=O)C)S(=O)(=O)C
-
化学全称N-(diaminomethylidene)-2-methyl-4,5-bis(methylsulfonyl)benzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Cox CS Jr, et al. Chest. 2003 Jan;123(1):187-94.
2. Corvera JS, et al .Ann Thorac Surg. 2003 Nov;76(5):1614-22.
3. Chen L, et al. Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H381-7.
4. Javadov S, et al. J Mol Cell Cardiol. 2005 Jan;38(1):135-43.
产品手册
关联产品
-
PF-05150122
PF-05150122 是一种有效的、状态依赖性、亚型选择性 Nav1.7 抑制剂,IC50 为 21 nM。
-
Oxybuprocaine hydroc...
盐酸奥布卡因是一种局部麻醉剂,特别用于眼科和耳鼻喉科。
-
BI 01383298
BI 01383298 是柠檬酸钠协同转运蛋白 (SLC13A5) 的选择性抑制剂。
021-51111890
购物车()
sales@molnova.cn

